Skip to main content
. 2018 Feb 15;26(4):798–814. doi: 10.1016/j.bmc.2017.12.015

Table 10.

Comparison of the RARα Agonist Potency, selectivity versus the RARβ and RARγ Human and Mouse Receptors, Human Intrinsic Clearance and Pharmacokinetic Profile in Rat for 56 and 15.

Binding Activity
Agonist Potency and Selectivity
PK
Compd RARα
rel IC50a
RARα
rel EC50
bm/chu
β/α
ratio
bm/chu
γ/α
ratio
bm/chu
intrinsic Clintd rat poe
f Log D
pH 7.4
human AUC Cl F%
56 3.6 1.6/0.6 200/298 11,000/>13,000 5.3 70,765 7 40 1.8
15 115 10.4/8.1 33/289 452/2322 26 1674 2 0.3 2.8
AM 580(2) 9 0.02/0.13 1130/162 826/505 15.6 2.8
a

RARα binding assay. The relative IC50 is the mean IC50 for each compound divided by the mean IC50 of ATRA (IC50 = 0.6 nM). Values were obtained from three separate experiments.

b

m = mouse receptor, see Table 1.

c

hu = human receptor, see Table 9.

d

Human microsomes Clint (µL/min/mg protein).

e

AUC po ng·min mL−1,Cl mL/kg/min.

f

Log D see Table 2.